Angiotech Pharmaceuticals, Inc. Announces Conference Call And Webcast
16 April 2009 - 2:30PM
PR Newswire (US)
First Quarter 2009 Financial Results VANCOUVER, April 16
/PRNewswire-FirstCall/ -- Angiotech Pharmaceuticals, Inc.
(NASDAQ:ANPINASDAQ:TSX:NASDAQ:ANP) will host a conference call
discussing its financial results for the first quarter ended March
31, 2009, on Thursday April 30, 2009 at 11:00 AM ET (8:00 AM
Pacific). Dial-in information for the earnings call on April 30,
2009 is as follows: North America (toll-free): (800) 901-5247
International: (617) 786-4501 Enter Passcode: 72734002 A live
webcast of the earnings call will be available to interested
parties through Angiotech's website at http://www.angiotech.com/ in
the Investor Relations section. A press release announcing
Angiotech's financial results will be issued prior to the call on
April 30 at approximately 8:00 AM ET (5:00 AM Pacific). An archived
replay of the call will be available until May 7, 2009. Replay
information is as follows: North America (toll-free): (888)
286-8010 International: (617) 801-6888 Enter Passcode: 95526962
About Angiotech Pharmaceuticals Angiotech Pharmaceuticals, Inc. is
a global specialty pharmaceutical and medical device company with
over 1,500 dedicated employees. Angiotech discovers, develops and
markets innovative treatment solutions for diseases or
complications associated with medical device implants, surgical
interventions and acute injury. To find out more about Angiotech
(NASDAQ:ANPINASDAQ:TSX:NASDAQ:ANP), please visit our website at
http://www.angiotech.com/. DATASOURCE: Angiotech Pharmaceuticals,
Inc. CONTACT: DeDe Sheel, Investor Relations and Corporate
Communications, Angiotech Pharmaceuticals, Inc., (415) 293-4412,
Copyright
Angiotech Pharmaceuticals - Common Shares (MM) (NASDAQ:ANPI)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
Angiotech Pharmaceuticals - Common Shares (MM) (NASDAQ:ANPI)
Historical Stock Chart
Von Jul 2023 bis Jul 2024
Echtzeit-Nachrichten über Angiotech Pharmaceuticals - Common Shares (MM) (NASDAQ): 0 Nachrichtenartikel
Weitere Angiotech Pharmaceuticals - Common Shares (MM) News-Artikel